Solutions

Functional brain-network data for complex neurosurgical decisions.

Objective brain function insights for more informed neurological care.

Supporting healthier brains through earlier insight.

Clinical Research

Empowering the next generation of neuroscience research.

Technology Resources

Reimbursement About Contact us

Delphi-MD Breakthrough Diagnostic Technology Promises to Reduce Healthcare Burden by Detecting Brain Abnormalities Prior to Symptoms

November 14, 2022

•

Join our newsletter to stay up to date on clinical updates and company news.

By subscribing you agree to our Privacy Policy and provide consent to receive updates from our company.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Solutions

Neurosurgery Neurology Brain Health Clinical Research Psychiatry

Company

Technology Partner Zone Resources About Us Contact

Follow us

© 2026 Quantalx. All rights reserved.

Privacy Policy Terms of Service

*All clinical interpretations of Delphi-MD™ assessments must be made by qualified healthcare professionals within the context of a full patient evaluation. The Delphi-MD™ system is intended to elicit, record, and analyze TMS-evoked brain potentials (TEPs) and provide quantitative output parameters compared against a normative reference database limited to ages 50–75. Adverse events during or after evaluation may include headache, nausea, dizziness, fatigue, insomnia, anxiety/agitation, back or neck pain, vomiting, tinnitus, migraine aura, and abnormal sensations. Delphi-MD™ is not intended to be relied upon solely to make or confirm a diagnosis. For more information, refer to the Delphi-MD™ user manual.